[ALA] QoQ Quarter Result on 30-Jun-2022 [#Q4]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- -100.04%
YoY- -41.55%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 13 380 714 273 137 23 11 11.79%
PBT -3,141 -4,948 -1,950 -4,671 -2,335 -3,950 -1,975 36.28%
Tax 0 -1,049 0 -0 0 -0 0 -
NP -3,141 -3,899 -1,950 -4,671 -2,335 -3,950 -1,975 36.28%
Tax Rate - - - - - - - -
Total Cost 3,154 4,279 2,664 4,944 2,472 3,973 1,986 36.15%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -23,877.58 -1,027.21 -272.98 -1,709.47 -1,709.48 -17,484.78 -17,484.01 23.11%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -
EPS Diluted -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.